Try our Chrome extension
Easily add the current web-page from your browser directly into your changedetection.io tool, more great features coming soon!
Chrome Webstore
Changedetection.io needs your support!
You can help us by supporting changedetection.io on these platforms;
- Rate us at AlternativeTo.net
- Star us on GitHub
- Follow us at Twitter/X
- Check us out on LinkedIn
- And tell your friends and colleagues :)
The more popular changedetection.io is, the more time we can dedicate to adding amazing features!
Many thanks :)
changedetection.io team
Not yet seconds ago
False
Not yet seconds ago
2 weeks ago
Pro-tip: Highlight text to add to ignore filters
Skip to content
* Home
* Team
* Portfolio
* Firm
* Press
* Contact
* Investor login
* Home
* Team
* Portfolio
* Firm
* Press
* Contact
* Investor login
Investor login
Venture capital for
Life Sciences
We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.
Founded in 2011,
venBio’s venture funds comprise nearly
in committed capital
$ 1.1 billion
approved drugs
1 FDA
diseases
FOR 1
Companies
that Matter
We are mindful of potential acquisition partners from the outset, and we ensure that our companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Our team’s expertise and involvement helps companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that we work with.
Our mission
We seek out teams who are developing treatments that will have a meaningful impact on patient care. Our mission is to put our companies in the best possible position to succeed, by helping teams think through the best development plan to bring these therapies to patients.
Learn more about us
Latest news
Sep 9, 2024
Candid Therapeutics Debuts with $370M Capital Raise
Read more
Aug 1, 2024
“venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies.”
Read more
Jul 23, 2024
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
Read more
View all news
* Home
* Team
* Portfolio
* Firm
* Press
* Contact
* Investor login
* Home
* Team
* Portfolio
* Firm
* Press
* Contact
* Investor login
* (415) 800-0800
* info@venbio.com
* linkedin
San Francisco office
1700 Owens Street, Suite 595
San Francisco, CA 94158
Seattle office
1200 Westlake Ave N, Suite 900
Seattle, WA 98109
© 2025 venBio. All Rights Reserved.
* Privacy Policy
* Terms of Use
* Privacy Policy
* Terms of Use
|
For now, Differences are performed on text, not graphically, only the latest screenshot is available.
Screenshot requires Playwright/WebDriver enabled